outstrip

Eli Lilly (LLY) shares were down slightly Tuesday despite reporting better-than-expected earnings on both the top and bottom lines for the final quarter of 2023, driven by an expected boost from GLP-1 products Mounjaro and Zepbound.The…

Almost two years ago, a special committee set up by the Israel Securities Authority and headed by Professor Yishai Yaffe presented a report stating that the investments of financial institutions failed to beat the returns…